메뉴 건너뛰기




Volumn 54, Issue 24, 2011, Pages 8670-8680

Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis c virus replication

Author keywords

[No Author keywords available]

Indexed keywords

2 ACETOXYBENZOYL N (5 CHLOROTHIAZOL 2 YL)AMIDE; 2 ACETOXYBENZOYL N (THIAZOL 2 YL)AMIDE; ANTIVIRUS AGENT; NITAZOXANIDE; UNCLASSIFIED DRUG;

EID: 84055176235     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm201264t     Document Type: Article
Times cited : (45)

References (70)
  • 1
    • 0004061813 scopus 로고    scopus 로고
    • 2nd ed.; Blackwell Publishing: Malden, MA
    • Wagner, E. K.; Hewlett, M. J. Basic Virology, 2nd ed.; Blackwell Publishing: Malden, MA, 2004; pp 242-243.
    • (2004) Basic Virology , pp. 242-243
    • Wagner, E.K.1    Hewlett, M.J.2
  • 2
    • 33747131043 scopus 로고    scopus 로고
    • Selective inhibitors of hepatitis C virus replication
    • Neyts, J. Selective inhibitors of hepatitis C virus replication. Antiviral Res. 2006, 71, 363-371.
    • (2006) Antiviral Res. , vol.71 , pp. 363-371
    • Neyts, J.1
  • 3
    • 0028998145 scopus 로고
    • Clinical outcomes after transfusion-associated hepatitis C
    • (a) Tong, M. J.; El-Ferra, N. S.; Reikes, A. R.; Co, R. L. Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 1995, 332, 1463-1466.
    • (1995) N. Engl. J. Med. , vol.332 , pp. 1463-1466
    • Tong, M.J.1    El-Ferra, N.S.2    Reikes, A.R.3    Co, R.L.4
  • 4
    • 0033545541 scopus 로고    scopus 로고
    • Rising incidence of hepatocellular carcinoma in the United States
    • (b) El-Serag, H. B.; Mason, A. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999, 34, 745-750.
    • (1999) N. Engl. J. Med. , vol.34 , pp. 745-750
    • El-Serag, H.B.1    Mason, A.2
  • 6
    • 0031059949 scopus 로고    scopus 로고
    • New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a
    • Ohno, T.; Mizokami, M.; Wu, R.-R.; Saleh, M. G.; Ohba, K.; Orito, E.; Mukaide, M.; Williams, R.; Lau, J. Y. N. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J. Clin. Microbiol. 1997, 35, 201-207.
    • (1997) J. Clin. Microbiol. , vol.35 , pp. 201-207
    • Ohno, T.1    Mizokami, M.2    Wu, R.-R.3    Saleh, M.G.4    Ohba, K.5    Orito, E.6    Mukaide, M.7    Williams, R.8    Lau, J.Y.N.9
  • 7
    • 68149131155 scopus 로고    scopus 로고
    • New therapeutic approaches to hepatitis C virus
    • Sakamoto, N.; Watanabe, M. New therapeutic approaches to hepatitis C virus. J. Gastroenterol. 2009, 44, 643-649.
    • (2009) J. Gastroenterol. , vol.44 , pp. 643-649
    • Sakamoto, N.1    Watanabe, M.2
  • 9
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomized trial
    • Manns, M. P.; McHutchinson, J. G.; Gordon, S. C.; Rustgi, V. K.; Shiffman, M.; Reindollar, R.; Goodman, Z. D.; Koury, K.; Ling, M.; Albrecht, J. K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001, 358, 958-965.
    • (2001) Lancet , vol.358 , pp. 958-965
    • Manns, M.P.1    McHutchinson, J.G.2    Gordon, S.C.3    Rustgi, V.K.4    Shiffman, M.5    Reindollar, R.6    Goodman, Z.D.7    Koury, K.8    Ling, M.9    Albrecht, J.K.10
  • 10
    • 67649382240 scopus 로고    scopus 로고
    • Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C
    • Rustgi, V. K. Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C. Curr. Med. Res. Opin. 2009, 25, 991-1002.
    • (2009) Curr. Med. Res. Opin. , vol.25 , pp. 991-1002
    • Rustgi, V.K.1
  • 13
    • 77958485628 scopus 로고    scopus 로고
    • A highly efficient synthesis of telaprevir by strategic use of biocatalysis and multicomponent reactions
    • Znabet, A.; Polka, M. M.; Janssen, E.; de Kanter, F. J. J.; Turner, N. J.; Orru, R. V. A.; Ruitjer, E. A highly efficient synthesis of telaprevir by strategic use of biocatalysis and multicomponent reactions. Chem. Commun. 2010, 46, 7918-7920.
    • (2010) Chem. Commun. , vol.46 , pp. 7918-7920
    • Znabet, A.1    Polka, M.M.2    Janssen, E.3    De Kanter, F.J.J.4    Turner, N.J.5    Orru, R.V.A.6    Ruitjer, E.7
  • 14
    • 33646036163 scopus 로고    scopus 로고
    • Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034
    • Tong, X.; Chase, R.; Skelton, A.; Chen, T.; Wright-Minogue, J.; Malcolm, B. A. Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034. Antiviral Res. 2006, 70, 28-38.
    • (2006) Antiviral Res. , vol.70 , pp. 28-38
    • Tong, X.1    Chase, R.2    Skelton, A.3    Chen, T.4    Wright-Minogue, J.5    Malcolm, B.A.6
  • 17
    • 42949167169 scopus 로고    scopus 로고
    • The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogues than to nonnucleoside analogues or protease inhibitors
    • McCown, M. F.; Rajyaguru, S.; Le Pogam, S.; Ali, S.; Jiang, W. R.; Kang, H.; Symons, J.; Cammack, N.; Najera, I. The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogues than to nonnucleoside analogues or protease inhibitors. Antimicrob. Agents Chemother. 2008, 52, 1604-1612.
    • (2008) Antimicrob. Agents Chemother. , vol.52 , pp. 1604-1612
    • McCown, M.F.1    Rajyaguru, S.2    Le Pogam, S.3    Ali, S.4    Jiang, W.R.5    Kang, H.6    Symons, J.7    Cammack, N.8    Najera, I.9
  • 18
    • 79954831999 scopus 로고    scopus 로고
    • NS5A inhibitors: A new breakthrough for the treatment of chronic hepatitis C
    • Asselah, T. NS5A inhibitors: a new breakthrough for the treatment of chronic hepatitis C. J. Hepatol. 2011, 54, 1069-1072.
    • (2011) J. Hepatol. , vol.54 , pp. 1069-1072
    • Asselah, T.1
  • 19
    • 0142182744 scopus 로고    scopus 로고
    • Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
    • Watashi, K.; Hijikata, M.; Hosaka, M.; Yamaji, M.; Shimotohno, K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003, 38, 1282-1288.
    • (2003) Hepatology , vol.38 , pp. 1282-1288
    • Watashi, K.1    Hijikata, M.2    Hosaka, M.3    Yamaji, M.4    Shimotohno, K.5
  • 22
    • 0032694353 scopus 로고    scopus 로고
    • Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents
    • (a) Zitzmann, N.; Mehta, A. S.; Carrouee, S.; Butters, T. D.; Platt, F. M.; McCauley, J.; Blumberg, B. S.; Dwek, R. A.; Block, T. M. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 11878-11882.
    • (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 11878-11882
    • Zitzmann, N.1    Mehta, A.S.2    Carrouee, S.3    Butters, T.D.4    Platt, F.M.5    McCauley, J.6    Blumberg, B.S.7    Dwek, R.A.8    Block, T.M.9
  • 23
    • 0036753024 scopus 로고    scopus 로고
    • The combination of interferon alpha-2b and N-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: Implications for hepatitis C virus (HCV) therapy
    • (b) Ouzounov, S.; Mehta, A.; Dwek, R. A.; Block, T. M.; Jordan, R. The combination of interferon alpha-2b and N-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Antiviral Res. 2008, 55, 425-435.
    • (2008) Antiviral Res. , vol.55 , pp. 425-435
    • Ouzounov, S.1    Mehta, A.2    Dwek, R.A.3    Block, T.M.4    Jordan, R.5
  • 25
    • 37449014458 scopus 로고    scopus 로고
    • Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication
    • Korba, B. E.; Montero, A. B.; Farrar, K.; Gaye, K.; Mukerjee, S.; Ayers, M. S.; Rossignol, J.-F. Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication. Antiviral Res. 2008, 77, 56-63.
    • (2008) Antiviral Res. , vol.77 , pp. 56-63
    • Korba, B.E.1    Montero, A.B.2    Farrar, K.3    Gaye, K.4    Mukerjee, S.5    Ayers, M.S.6    Rossignol, J.-F.7
  • 26
  • 28
    • 79960455704 scopus 로고    scopus 로고
    • Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells
    • Yon, C.; Viswanathan, P.; Rossignol, J.-F.; Korba, B. E. Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells. Antiviral Res. 2011, 91, 233-240.
    • (2011) Antiviral Res. , vol.91 , pp. 233-240
    • Yon, C.1    Viswanathan, P.2    Rossignol, J.-F.3    Korba, B.E.4
  • 29
    • 60449108708 scopus 로고    scopus 로고
    • Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon and ribavirin
    • Rossignol, J.-F.; Elfert, A.; El-Gohary, Y.; Keeffe, E. B. Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon and ribavirin. Gastroenterology 2009, 136, 856-862.
    • (2009) Gastroenterology , vol.136 , pp. 856-862
    • Rossignol, J.-F.1    Elfert, A.2    El-Gohary, Y.3    Keeffe, E.B.4
  • 30
    • 77955146829 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide
    • (a) Rossignol, J.-F.; Elferty, A.; Keeffe, E. B. Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide. J. Clin. Gastroenterol. 2010, 44, 504-509.
    • (2010) J. Clin. Gastroenterol. , vol.44 , pp. 504-509
    • Rossignol, J.-F.1    Elferty, A.2    Keeffe, E.B.3
  • 31
    • 60449096365 scopus 로고    scopus 로고
    • Potential role for nitazoxanide in combination with STAT-C agents for the inhibition of HCV replication without the development of resistance
    • (b) Korba, B. E.; Elazar, M.; Lui, P.; Glenn, J. S.; Rossignol, J.-F. Potential role for nitazoxanide in combination with STAT-C agents for the inhibition of HCV replication without the development of resistance. Hepatology 2008, 48 (Suppl.), 356A.
    • (2008) Hepatology , vol.48 , Issue.SUPPL.
    • Korba, B.E.1    Elazar, M.2    Lui, P.3    Glenn, J.S.4    Rossignol, J.-F.5
  • 32
    • 0018216945 scopus 로고
    • Recherches sur les dérivés nitrés d'intérêt biologique. XVI. Relations entre structures et activités protozoocides antheminthiques et molluscicides dans la série du benzamido-2 nitro-5 thiazole
    • Cavier, R.; Gayral, Ph.; Guillaumel, J.; Clavel, J. M.; Demerseman, P.; Royer, R. Recherches sur les dérivés nitrés d'intérêt biologique. XVI. Relations entre structures et activités protozoocides antheminthiques et molluscicides dans la série du benzamido-2 nitro-5 thiazole. Eur. J. Med. Chem. 1978, 13, 539-543.
    • (1978) Eur. J. Med. Chem. , vol.13 , pp. 539-543
    • Cavier, R.1    Gayral, Ph.2    Guillaumel, J.3    Clavel, J.M.4    Demerseman, P.5    Royer, R.6
  • 34
    • 12444265690 scopus 로고    scopus 로고
    • Inhibitors of type I MetAPs containing pyridine-2-carboxylic acid thiazol-2-ylamide. Part I: Sar studies on the determination of the key scaffold
    • (a) Luo, Q.-L.; Li, J.-Y.; Liu, Z.-Y; Chen, L.-L.; Li, J.; Ye, Q.-Z.; Nan, F.-J. Inhibitors of type I MetAPs containing pyridine-2-carboxylic acid thiazol-2-ylamide. Part I: SAR studies on the determination of the key scaffold. Bioorg. Med. Chem. Lett. 2005, 15, 635-638.
    • (2005) Bioorg. Med. Chem. Lett. , vol.15 , pp. 635-638
    • Luo, Q.-L.1    Li, J.-Y.2    Liu, Z.-Y.3    Chen, L.-L.4    Li, J.5    Ye, Q.-Z.6    Nan, F.-J.7
  • 36
    • 84055216896 scopus 로고
    • U.S. Patent 2401522
    • (c) U.S. Patent 2401522, 1943; Sandoz.
    • (1943)
    • Sandoz1
  • 38
    • 0000729721 scopus 로고
    • 1-(Trifluoromethy1)ethenyl phenyl selenide and1-(trifluoromethy1)ethenyl phenyl sulfide
    • Feiring, A. E. 1-(Trifluoromethy1)ethenyl phenyl selenide and1-(trifluoromethy1)ethenyl phenyl sulfide. J. Org. Chem. 1980, 45, 1962-1964.
    • (1980) J. Org. Chem. , vol.45 , pp. 1962-1964
    • Feiring, A.E.1
  • 39
    • 12344307019 scopus 로고    scopus 로고
    • Investigations of the halogen dance reaction on N-substituted 2-thiazolamines
    • Stanetty, P.; Schnurch, M.; Mereiter, K.; Mihovilovic, M. D. Investigations of the halogen dance reaction on N-substituted 2-thiazolamines. J. Org. Chem. 2005, 70, 567-574.
    • (2005) J. Org. Chem. , vol.70 , pp. 567-574
    • Stanetty, P.1    Schnurch, M.2    Mereiter, K.3    Mihovilovic, M.D.4
  • 40
    • 0036291061 scopus 로고    scopus 로고
    • Preparation of N-tert-butoxycarbonylthiourea opens the way to protected 2-aminothiazoles
    • Schiavi, B.; Ahond, A.; Poupat, C.; Potier, P. Preparation of N-tert-butoxycarbonylthiourea opens the way to protected 2-aminothiazoles. Synth. Commun. 2002, 32, 1671-1674.
    • (2002) Synth. Commun. , vol.32 , pp. 1671-1674
    • Schiavi, B.1    Ahond, A.2    Poupat, C.3    Potier, P.4
  • 41
    • 0242362591 scopus 로고    scopus 로고
    • Design, synthesis, and biological evaluation of 6-substituted-3-(4- methanesulfonylphenyl)-4-phenylpyran-2-ones: A novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors
    • Praveen Rao, P. N.; Amini, M.; Li, H.; Habeeb, A. G.; Knaus, E. E. Design, synthesis, and biological evaluation of 6-substituted-3-(4- methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors. J. Med. Chem. 2003, 46, 4872-4882.
    • (2003) J. Med. Chem. , vol.46 , pp. 4872-4882
    • Praveen Rao, P.N.1    Amini, M.2    Li, H.3    Habeeb, A.G.4    Knaus, E.E.5
  • 44
    • 0035153842 scopus 로고    scopus 로고
    • Computational methods to estimate drug development parameters
    • Podlogar, B. L.; Muegge, I.; Brice, L. J. Computational methods to estimate drug development parameters. Curr. Opin. Drug Discovery 2001, 4, 102-109.
    • (2001) Curr. Opin. Drug Discovery , vol.4 , pp. 102-109
    • Podlogar, B.L.1    Muegge, I.2    Brice, L.J.3
  • 45
    • 0043132440 scopus 로고    scopus 로고
    • Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs
    • Eriksson, L.; Jaworska, J.; Worth, A. P.; Cronin, M. T. D.; McDowell, R. M. M.; Gramatica, P. Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ. Health Perspect. 2003, 111, 1361-1375.
    • (2003) Environ. Health Perspect. , vol.111 , pp. 1361-1375
    • Eriksson, L.1    Jaworska, J.2    Worth, A.P.3    Cronin, M.T.D.4    McDowell, R.M.M.5    Gramatica, P.6
  • 46
    • 84855609127 scopus 로고    scopus 로고
    • (accessed Aug 19, 2011)
    • PHAKISO: Pharmacokinetics in Silico. http://www.phakiso.com/ (accessed Aug 19, 2011).
    • Pharmacokinetics in Silico
  • 47
    • 84867234414 scopus 로고    scopus 로고
    • DRAGON version 6.0; Talete srl: Milan, Italy
    • DRAGON (Software for Molecular Descriptor Calculation), version 6.0; Talete srl: Milan, Italy, 2010; http://www.talete.mi.it/.
    • (2010) Software for Molecular Descriptor Calculation
  • 49
    • 0038724207 scopus 로고    scopus 로고
    • The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSAR models
    • Tropsha, A.; Gramatica, P.; Gombar, V. K. The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSAR models. QSAR Comb. Sci. 2003, 22, 69-77.
    • (2003) QSAR Comb. Sci. , vol.22 , pp. 69-77
    • Tropsha, A.1    Gramatica, P.2    Gombar, V.K.3
  • 50
    • 84894887900 scopus 로고
    • Computer aided design of experiments
    • Kennard, R. W.; Stone, L. A. Computer aided design of experiments. Technometric 1969, 11, 137-148.
    • (1969) Technometric , vol.11 , pp. 137-148
    • Kennard, R.W.1    Stone, L.A.2
  • 52
    • 20444410410 scopus 로고    scopus 로고
    • Virtual screening of molecular databases using a support vector machine
    • (a) Jorissen, R. N.; Gilson, M. K. Virtual screening of molecular databases using a support vector machine. J. Chem. Inf. Model. 2005, 45, 549-561.
    • (2005) J. Chem. Inf. Model. , vol.45 , pp. 549-561
    • Jorissen, R.N.1    Gilson, M.K.2
  • 53
    • 33646420101 scopus 로고    scopus 로고
    • Statistical learning approach for predicting specific pharmacodynamic, pharmacokinetic or toxicological properties of pharmaceutical agents
    • (b) Li, H.; Yap, C. W.; Xue, Y.; Li, Z. R.; Ung, C. Y.; Han, L. Y.; Chen, Y. Z. Statistical learning approach for predicting specific pharmacodynamic, pharmacokinetic or toxicological properties of pharmaceutical agents. Drug Dev. Res. 2006, 66, 245-259.
    • (2006) Drug Dev. Res. , vol.66 , pp. 245-259
    • Li, H.1    Yap, C.W.2    Xue, Y.3    Li, Z.R.4    Ung, C.Y.5    Han, L.Y.6    Chen, Y.Z.7
  • 55
    • 48449083690 scopus 로고    scopus 로고
    • Studies of the potential for resistance to nitazoxanide or tizoxanide
    • Korba, B. E.; Glenn, J. S.; Ayers, M. S.; Rossignol, J.-F. Studies of the potential for resistance to nitazoxanide or tizoxanide. J. Hepatol. 2008, 48, S11.
    • (2008) J. Hepatol. , vol.48
    • Korba, B.E.1    Glenn, J.S.2    Ayers, M.S.3    Rossignol, J.-F.4
  • 56
    • 70350365369 scopus 로고    scopus 로고
    • Thiazolides, a new class of anti-influenza molecules targeting viral haemagglutinin at the post-translational level
    • Rossignol, J.-F.; La Frazia, S.; Chiappa, L.; Ciucci, A.; Santoro, M. G. Thiazolides, a new class of anti-influenza molecules targeting viral haemagglutinin at the post-translational level. J. Biol. Chem. 2009, 284, 29798-29808.
    • (2009) J. Biol. Chem. , vol.284 , pp. 29798-29808
    • Rossignol, J.-F.1    La Frazia, S.2    Chiappa, L.3    Ciucci, A.4    Santoro, M.G.5
  • 57
    • 70350125916 scopus 로고    scopus 로고
    • The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2 alpha via protein kinase activated by double-stranded RNA activation
    • Elazar, M.; Liu, M.; McKenna, S. A.; Liu, P.; Gehrig, E. A.; Puglisi, J. D.; Rossignol, J.-F.; Glenn, J. S. The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2 alpha via protein kinase activated by double-stranded RNA activation. Gastroenterology 2009, 137, 1827-1835.
    • (2009) Gastroenterology , vol.137 , pp. 1827-1835
    • Elazar, M.1    Liu, M.2    McKenna, S.A.3    Liu, P.4    Gehrig, E.A.5    Puglisi, J.D.6    Rossignol, J.-F.7    Glenn, J.S.8
  • 58
    • 37549030572 scopus 로고    scopus 로고
    • Anion-triggered substituent-dependent conformational switching of salicylanilides. New hints for understanding the inhibitory mechanism of salicylanilides
    • Guo, L.; Wang, Q.-L.; Jiang, Q.-Q.; Jiang, Q.-J.; Jiang, Y.-B. Anion-triggered substituent-dependent conformational switching of salicylanilides. New hints for understanding the inhibitory mechanism of salicylanilides. J. Org. Chem. 2007, 72, 9947-9953.
    • (2007) J. Org. Chem. , vol.72 , pp. 9947-9953
    • Guo, L.1    Wang, Q.-L.2    Jiang, Q.-Q.3    Jiang, Q.-J.4    Jiang, Y.-B.5
  • 59
    • 33747154401 scopus 로고    scopus 로고
    • Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development
    • Kamath, S.; Buolamwini, J. K. Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development. Med. Res. Rev. 2006, 26, 569-594.
    • (2006) Med. Res. Rev. , vol.26 , pp. 569-594
    • Kamath, S.1    Buolamwini, J.K.2
  • 61
    • 0034623816 scopus 로고    scopus 로고
    • Efficient initiation of HCV RNA replication in cell culture
    • Blight, K. J.; Kolykhalov, A. A.; Rice, C. M. Efficient initiation of HCV RNA replication in cell culture. Science 2000, 290, 1972-1974.
    • (2000) Science , vol.290 , pp. 1972-1974
    • Blight, K.J.1    Kolykhalov, A.A.2    Rice, C.M.3
  • 62
    • 11844269964 scopus 로고    scopus 로고
    • Enhancement of antiviral activity against hepatitic C virus in vitro by interferon combination therapy
    • Okuse, C.; Rinaudo, J. A.; Farrar, K.; Wells, F.; Korba, B. E. Enhancement of antiviral activity against hepatitic C virus in vitro by interferon combination therapy. Antiviral Res. 2005, 65, 23-34.
    • (2005) Antiviral Res. , vol.65 , pp. 23-34
    • Okuse, C.1    Rinaudo, J.A.2    Farrar, K.3    Wells, F.4    Korba, B.E.5
  • 63
    • 0037370622 scopus 로고    scopus 로고
    • Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture
    • Blight, K. J.; McKeating, J. A.; Marcotrigiano, J.; Rice, C. M. Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J. Virol. 2003, 77, 3181-3190.
    • (2003) J. Virol. , vol.77 , pp. 3181-3190
    • Blight, K.J.1    McKeating, J.A.2    Marcotrigiano, J.3    Rice, C.M.4
  • 64
    • 84855574482 scopus 로고    scopus 로고
    • Wavefunction, Inc. http://www.wavefun.com/.
  • 66
    • 0024349286 scopus 로고
    • Corchop, an interactive routine for the dimension reduction of large QSAR data sets
    • Livingstone, D. J.; Rahr, E. Corchop, an interactive routine for the dimension reduction of large QSAR data sets. Quant. Struct.-Act. Relat. 1989, 8, 103-108.
    • (1989) Quant. Struct.-act. Relat. , vol.8 , pp. 103-108
    • Livingstone, D.J.1    Rahr, E.2
  • 67
    • 0018709674 scopus 로고
    • Chance factors in studies of quantitative structure-activity relationships
    • Topliss, J. G.; Edwards, R. P. Chance factors in studies of quantitative structure-activity relationships. J. Med. Chem. 1979, 22, 1238-1244.
    • (1979) J. Med. Chem. , vol.22 , pp. 1238-1244
    • Topliss, J.G.1    Edwards, R.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.